COVID- 19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: In addition to routine treatment, 30 cc (every 12 hours 15 cc) of virgin coconut oil is consumed orally in pure form or with milk or soup. Routine treatment include
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients 18-80 years old have been diagnosed COVID-19, According to the information registration system of Mashhad University of Medical Sciences hospitalized at home
Exclusion criteria
Exclusion criteria: History of Allergy to coconut and its derivatives Dissatisfaction with inclusion in the study Severe illness and need for hospitalization
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weakness. Timepoint: End of the first and second week. Method of measurement: According to the VAS criteria. | — |
Secondary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: At the end of the first and second week. Method of measurement: Thermometer.;Intensity and frequency of cough. Timepoint: At the end of the first and second week. Method of measurement: Visual Scale Scoring or VAS.;Myalgia. Timepoint: At the end of the first and second week. Method of measurement: Visual Scale Scoring or VAS.;Respiratory rate. Timepoint: At the end of the first and second week. Method of measurement: count respiratory rate in one minute.;Hospitalization. Timepoint: At the end of the first and second week. Method of measurement: The ratio of the number of cases leading to hospitalization to the total number of patients in each group. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactGhazaleh Ghorbannezhad
Mashhad University of Medical Sciences
Outcome results
None listed